![Jian Sun](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jian Sun
Corporate Officer/Principal chez Lianyuangang Chia Tai Tianqing Medicine Co., Ltd.
Postes actifs de Jian Sun
Sociétés | Poste | Début | Fin |
---|---|---|---|
Lianyuangang Chia Tai Tianqing Medicine Co., Ltd. | Corporate Officer/Principal | 19/08/2011 | - |
Historique de carrière de Jian Sun
Anciens postes connus de Jian Sun
Sociétés | Poste | Début | Fin |
---|---|---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
![]() Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | President | 19/08/2011 | - |
Statistiques
Internationale
Chine | 3 |
Opérationnelle
President | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
![]() Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
Lianyuangang Chia Tai Tianqing Medicine Co., Ltd. |